Howden CW - Search Results

1

The relationship between suppression of acidity and gastric ulcer healing rates.

Howden CW, Hunt RH. Howden CW, et al. Aliment Pharmacol Ther. 1990 Feb;4(1):25-33. doi: 10.1111/j.1365-2036.1990.tb00445.x. Aliment Pharmacol Ther. 1990. PMID: 2151756

2

Systematic review and meta-analysis: proton-pump inhibitor treatment for ulcer bleeding reduces transfusion requirements and hospital stay--results from the Cochrane Collaboration.

Leontiadis GI, Sharma VK, Howden CW. Leontiadis GI, et al. Among authors: howden cw. Aliment Pharmacol Ther. 2005 Aug 1;22(3):169-74. doi: 10.1111/j.1365-2036.2005.02546.x. Aliment Pharmacol Ther. 2005. PMID: 16091053 Review.

3

Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression.

Kahrilas PJ, Persson T, Denison H, Wernersson B, Hughes N, Howden CW. Kahrilas PJ, et al. Among authors: howden cw. Aliment Pharmacol Ther. 2014 Sep;40(6):648-56. doi: 10.1111/apt.12877. Epub 2014 Jul 15. Aliment Pharmacol Ther. 2014. PMID: 25039978 Clinical Trial.

4

Clinical trial: efficacy and safety of dexlansoprazole MR 60 and 90 mg in healed erosive oesophagitis - maintenance of healing and symptom relief.

Howden CW, Larsen LM, Perez MC, Palmer R, Atkinson SN. Howden CW, et al. Aliment Pharmacol Ther. 2009 Nov 1;30(9):895-907. doi: 10.1111/j.1365-2036.2009.04119.x. Epub 2009 Aug 14. Aliment Pharmacol Ther. 2009. PMID: 19681809 Clinical Trial.

5

Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.

Elnachef N, Scheiman JM, Fendrick AM, Howden CW, Chey WD. Elnachef N, et al. Among authors: howden cw. Aliment Pharmacol Ther. 2008 Nov 15;28(10):1249-58. doi: 10.1111/j.1365-2036.2008.03836.x. Epub 2008 Aug 22. Aliment Pharmacol Ther. 2008. PMID: 18729848

6

Review article: the clinical pharmacology of proton pump inhibitors.

Sachs G, Shin JM, Howden CW. Sachs G, et al. Among authors: howden cw. Aliment Pharmacol Ther. 2006 Jun;23 Suppl 2:2-8. doi: 10.1111/j.1365-2036.2006.02943.x. Aliment Pharmacol Ther. 2006. PMID: 16700898 Review.

7

Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h.

Howden CW, Metz DC, Hunt B, Vakily M, Kukulka M, Amer F, Samra N. Howden CW, et al. Aliment Pharmacol Ther. 2006 Apr 1;23(7):975-84. doi: 10.1111/j.1365-2036.2006.02849.x. Aliment Pharmacol Ther. 2006. PMID: 16573800 Clinical Trial.

8

Review article: immediate-release proton-pump inhibitor therapy--potential advantages.

Howden CW. Howden CW. Aliment Pharmacol Ther. 2005 Dec;22 Suppl 3:25-30. doi: 10.1111/j.1365-2036.2005.02709.x. Aliment Pharmacol Ther. 2005. PMID: 16303034 Review.

9

Systematic review and meta-analysis: enhanced efficacy of proton-pump inhibitor therapy for peptic ulcer bleeding in Asia--a post hoc analysis from the Cochrane Collaboration.

Leontiadis GI, Sharma VK, Howden CW. Leontiadis GI, et al. Among authors: howden cw. Aliment Pharmacol Ther. 2005 May 1;21(9):1055-61. doi: 10.1111/j.1365-2036.2005.02441.x. Aliment Pharmacol Ther. 2005. PMID: 15854166 Review.

10

PPI vs. teprenone in preventing recurrence of ulcers during low-dose aspirin.

Howden CW. Howden CW. Aliment Pharmacol Ther. 2014 Dec;40(11-12):1367. doi: 10.1111/apt.12982. Aliment Pharmacol Ther. 2014. PMID: 25376205 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results